Postsynaptic 5-HT(1A) receptors control 5-HT release in the rat medial prefrontal cortex

NeuroReport

Volumn 10, Issue 7, 1999, Pages 1441-1445

  Casanovas, Josep M ^a   Hervás, Ildefonso ^a   Artigas, Francesc ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

5 HT release; 5 HT(1A) receptors; Dorsal raphe nucleus; Hippocampus; Medial prefrontal cortex; Microdialysis; Pyramidal neurones; Striatum

Indexed keywords

2 DIBUTYLAMINO 8 HYDROXYTETRALIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; POSTSYNAPTIC RECEPTOR; REPINOTAN; SEROTONIN; SEROTONIN 1A RECEPTOR; 2 DIPROPYLAMINO 8 HYDROXYTETRALIN; BENZOPYRAN DERIVATIVE; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR; THIAZOLE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; COGNITION; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG EFFECT; DRUG RECEPTOR BINDING; HIPPOCAMPUS; MICRODIALYSIS; MOOD; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; RAT; RECEPTOR OCCUPANCY; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; ANALYSIS OF VARIANCE; ANIMAL; CYTOLOGY; MALE; METABOLISM; NERVE CELL; PHYSIOLOGY; SYNAPSE; WISTAR RAT;

8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANALYSIS OF VARIANCE; ANIMALS; BENZOPYRANS; MALE; NEURONS; PIPERAZINES; PREFRONTAL CORTEX; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SYNAPSES; THIAZOLES;

EID: 0033553221     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199905140-00010     Document Type: Article

References (29)

1. 1. Jacobs BL and Azmitia EC. Physiol Rev 72, 165-229 (1992).
2. 2. Aghajanian GK and Lakoski JM. Brain Res 305, 181-185 (1984).
3. 3. Sprouse JS and Aghajanian GK. Eur J Pharmacol 128, 295-298 (1986).
4. 4. Sharp T, Bramwell SR and Grahame-Smith DG. Br J Pharmacol 96, 283-290 (1989).
5. 5. Adell A, Carceller A and Artigas F. J Neurochem 60, 1673-1681 (1993).
6. 6. Pompeiano M, Palacios JM and Mengod G. J Neurosci 12, 440-453 (1992).
7. 7. Araneda R and Andrade R. Neuroscience 40, 399-412 (1991).
8. 8. Blier P and de Montigny C. Synapse 1, 470-480 (1987).
9. 9. Ceci A, Baschirotto A and Borsini F. Neuropharmacology 33, 709-713 (1994).
10. 10. Romero L, Celada P and Artigas F. Eur J Pharmacol 265, 103-106 (1994).
11. 11. Casanovas JM and Artigas F. J Neurochem 67, 1945-1952 (1996).
12. 12. Casanovas JM, Lésourd M and Artigas F. Br J Pharmacol 122, 733-741 (1997).
13. 13. Azmitia EC and Segal M. J Comp Neurol 179, 641-668 (1978).
14. 14. McQuade R. and Sharp T. J Neurochem 69, 791-796 (1997).
15. 15. Adell A and Artigas F. Br J Pharmacol 125, 1162-1167 (1998).
16. 16. Paxinos G and Watson C. The Rat Brain in Stereotaxic Coordinates. Sydney: Academic Press, 1986.
17. 17. De Vry J. Psychopharmacology 121, 1-26 (1995).
18. 18. File SE, Gonzalez LE and Andrews N. J Neurosci 16, 4810-4815 (1996).
19. 19. Jolas T, Schreiber R, Laporte AM et al. J Pharmacol Exp Ther 272, 920-929 (1995).
20. 20. Casanovas JM, Paez X and Artigas F. Soc Neurosci Abstr 24, 1105 (1998).
21. 21. Kia HK, Brisorgueil MJ, Hamon M et al. J Neurosci Res 46, 697-708 (1996).
22. 22. Hajos M, Richards CD, Szekely AD and Sharp T. Neuroscience 87, 95-108 (1998).
23. 23 Peyron C, Petit JM, Rampon C et al. Neuroscience 82, 443-468 (1998).
24. 24. Artigas F, Casanovas JM and Hervás I. Soc Neurosci Abstr 24, 1365 (1998).
25. 25. Romero L and Artigas F. J Neurochem 68, 2593-2603 (1997).
26. 26. Hamon M, Bourgoin S, Gozlan H et al. Eur J Pharmacol 100, 263-276 (1984).
27. 27. Johnson EA, Tsai CE, Shahan YH and Azzaro AJ. J Pharmacol Exp Ther 266, 133-141 (1993).
28. 28. Assie MB and Koek W. Br J Pharmacol 119, 845-850 (1996).
29. 29. De Vry J, Schohe-Loop R, Heine HG et al. J Pharmacol Exp Ther 284, 1082-1094 (1998).